HDAC2 and hepatocellular carcinoma: As HDAC inhibitor treatment and knockdown of HDAC1 and HDAC2 invariably lead to FBP1 upregulation, next we were interested to decipher the molecular mechanism of HDAC-mediated repression of FBP1 in HCC cells.